Suggestions

Du même auteur

Benefit-risk profile of dabigatran compared with vitamin-K antagonists in elderly patients with non-valvular atrial fibrillation: results from a cohort study in the French nationwide claims database. : European Heart Journal

Archive ouverte | Cottin, Y. | CCSD

International audience

Effectiveness and safety of standard and reduced doses of dabigatran versus rivaroxaban in non-valvular atrial fibrillation: A cohort study in the snds french nationwide claims database. : Value in Health

Archive ouverte | Blin, P. | CCSD

International audience

Effectiveness and Safety of Standard and Reduced Doses of Dabigatran Compared to Rivaroxaban in Nonvalvular Atrial Fibrillation: Long-Term Results from a Cohort Study in the French Nationwide Claims Database. : J Am Coll Cardiol

Archive ouverte | Moore, Nicholas | CCSD

International audience. BackgroundDabigatran (D) and rivaroxaban (R) showed better benefit-risk than vitamin K antagonists for stroke prevention in nonvalvular atrial fibrillation (NVAF), but there is no direct face...

Chargement des enrichissements...